Beyond Antibiotics: A New Strategy to Combat Superbugs Using a Cow Enzyme

A looming threat is making our hospitals less safe and our medicines less effective. The World Health Organization has singled out a particular bacterium, Klebsiella pneumoniae, as a critical health threat. This superbug is a leading cause of infections acquired in hospitals, causing serious illnesses from pneumonia to meningitis. It’s especially dangerous for people with … Read more

Warning to Farmers: Your Probiotics Might Be Breeding Resistant Bacteria

The very supplements farmers use to keep their livestock healthy might be silently contributing to a global health emergency. Startling new research from China reveals that many probiotic products for animals, intended as a safe alternative to antibiotics, are not only falling short on quality but are also acting as unwitting carriers of antibiotic resistance. … Read more

Why Your Gut’s Hidden DNA Could Be as Risky as High Blood Pressure

Nurse taking patient's blood pressure

For decades, we’ve heard about antibiotic resistance as a global health crisis, a silent threat making once-treatable infections deadly. But what if the very bacteria living peacefully in your gut, the ones you rarely think about, are silently increasing your personal risk for serious health issues, even death? A groundbreaking study from Finland reveals a … Read more

Cow Enzyme Fights Superbugs: A Breakthrough in Antibiotic Resistance

In a world increasingly threatened by bacteria that shrug off our most powerful medicines, the rise of “superbugs” is a chilling reality. One such formidable adversary is Klebsiella pneumoniae, a bacterium often found in hospitals that can cause severe infections like pneumonia and meningitis. The World Health Organization has labeled it a “critical threat pathogen,” … Read more

New biotherapeutic protects gut microbiome from harmful effects of antibiotics

Definition of antibiotics

A team of scientists at Harvard University and the Massachusetts Institute of Technology (MIT) collaborated to develop a live biotherapeutic product (eLBP) that, when given together with commonly used antibiotics, protects the gut microbiome from adverse disturbance.